⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL50847 | 0.59 | — | — | |
| SCHEMBL308390 | 0.59 | — | — | |
| SCHEMBL16144793 | 0.59 | — | — | |
| SCHEMBL10368984 | 0.59 | — | — | |
| SCHEMBL14601152 | 0.59 | — | — | |
| SCHEMBL190778 | 0.56 | — | — | |
| SCHEMBL2701798 | 0.56 | — | — | |
| SCHEMBL64332 | 0.56 | — | — | |
| SCHEMBL4923930 | 0.56 | — | — | |
| SCHEMBL28661 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1398317-B1 | ALICYCLIC COMPOUND FOR OPTICAL MATERIAL | MITSUBISHI GAS CHEMICAL CO (JP) | 2011-01-12 | — | — | EP | claimed |
| US-7301705-B2 | Alicyclic compound for optical material | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2007-11-27 | — | — | US | claimed |
| US-20040158031-A1 | Alicyclic compound for optical material | MITSUBISHI GAS CHEMICAL CO., INC. (JP) | 2004-08-12 | — | — | US | claimed |
| EP-1398317-A1 | ALICYCLIC COMPOUND FOR OPTICAL MATERIAL | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2004-03-17 | — | — | EP | claimed |
| EP-4385520-A2 | GLYCOTARGETING THERAPEUTICS | Ecole Polytechnique Fédérale de Lausanne (CH) | 2024-06-19 | — | — | EP | disclosed |
| EP-4359419-A1 | PRODRUGS WITH 1-(DISULFANYL)ALKYLOXY-CARBONYL UNITS | Pharmacytics B.V. (NL) | 2024-05-01 | — | — | EP | disclosed |
| CN-117858882-A | Prodrugs having 1- (disulfanyl) alkoxy-carbonyl units | 药物有限公司 | 2024-04-09 | — | — | CN | disclosed |
| US-11801305-B2 | Glycotargeting therapeutics | ÉCOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (EPFL) (CH) | 2023-10-31 | — | — | US | disclosed |
| US-11793882-B2 | Glycotargeting therapeutics | ÉCOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (EPFL) (CH) | 2023-10-24 | — | — | US | disclosed |
| CN-116413326-A | Method for determining crude oil source based on thioethyl noradamantane | 中国石油天然气股份有限公司 | 2023-07-11 | — | — | CN | disclosed |
| WO-2023124748-A1 | METHOD FOR DETERMINING CRUDE OIL SOURCE BASED ON THIOETHYL NORADAMANTANE | 中国石油天然气股份有限公司 | 2023-07-06 | — | — | WO | disclosed |
| EP-3728280-B1 | METHOD FOR IMPROVING THE ORAL BIOAVAILABILITY OF A DRUG | PHARMACYTICS B V (NL) | 2023-06-28 | — | — | EP | disclosed |
| EP-1140984-A1 | SELECTIVE INHIBITORS OF MMP-12 | Aventis Pharmaceuticals Inc. (US) | 2001-10-10 | — | — | EP | disclosed |
| EP-1140818-A1 | AMIDOMALONAMIDES AND THEIR USE AS INHIBITORS OF MATRIX METALLOPROTEINASE | Aventis Pharmaceuticals Inc. (US) | 2001-10-10 | — | — | EP | disclosed |
| US-6262080-B1 | 3-(thio-substitutedamido)-lactams useful as inhibitors of matrix metalloproteinase | AVANTIS PHARMACEUTICALS INC. | 2001-07-17 | — | — | US | disclosed |
| WO-2000040564-A1 | N-CARBOXYMETHYL SUBSTITUTED BENZOLACTAMS AS INHIBITORS OF MATRIX METALLOPROTEINASE | AVENTIS PHARMACEUTICALS INC. (US) | 2000-07-13 | — | — | WO | disclosed |
| WO-2000040552-A1 | AMIDOMALONAMIDES AND THEIR USE AS INHIBITORS OF MATRIX METALLOPROTEINASE | AVENTIS PHARMACEUTICALS INC. (US) | 2000-07-13 | — | — | WO | disclosed |
| WO-2000040578-A1 | 3-(THIO-SUBSTITUTED AMIDO)-LACTAMS USEFUL AS INHIBITORS OF MATRIX METALLOPROTEINASE | AVENTIS PHARMACEUTICALS INC. (US) | 2000-07-13 | — | — | WO | disclosed |
| WO-2000040600-A1 | SELECTIVE INHIBITORS OF MMP-12 | AVENTIS PHARMACEUTICALS INC. (US) | 2000-07-13 | — | — | WO | disclosed |
| WO-2000040553-A1 | 3-SUBSTITUTED PYRROLIDINES USEFUL AS INHIBITORS OF MATRIX METALLO-PROTEINASES | AVENTIS PHARMACEUTICALS INC. (US) | 2000-07-13 | — | — | WO | disclosed |